Market cap
₹21 Cr
Revenue (TTM)
₹8 Cr
P/E Ratio
--
P/B Ratio
2.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 27.71 | 15.15 | -- |
| EBIT | -- | -- | -278.30 | -209.85 | -- |
| Net Profit | -- | -- | -319.99 | -222.19 | -- |
| EPS | -- | -- | -319.99 | -200.17 | -- |
| Book Value | -- | -- | -7.00 | 49.01 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| 3.21 | -- | -9.20 | 5.88 | -- |
| Net Margin
| 1.55 | -- | -8.39 | 4.37 | -- |
| Return on equity
| 6.15 | -- | -8.74 | 3.38 | -- |
| Return on Capital
| 8.43 | -- | -3.35 | 4.62 | -- |
| Return on Assets
| 3.27 | -- | -5.17 | 2.34 | -- |
| Debt to Equity (x)
| -- | -- | 0.85 | 0.34 | -- |
Profitability
ROCE
-3.35
Lower than Peers by 16.83
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-3.35
|
4.62
|
--
|
--
|
--
|
|
Peer Median
|
13.49
|
12.19
|
11.06
|
9.85
|
--
|
ROE
-8.74
Lower than Peers by 19.98
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-8.74
|
3.38
|
--
|
--
|
--
|
|
Peer Median
|
11.24
|
9.26
|
7.17
|
7.54
|
--
|
ROA
-5.17
Lower than Peers by 11.16
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-5.17
|
2.34
|
--
|
--
|
--
|
|
Peer Median
|
6.00
|
7.65
|
3.78
|
3.99
|
--
|
EBIT Margin
-9.20
Lower than Peers by 30.57
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-9.20
|
5.88
|
--
|
--
|
--
|
|
Peer Median
|
21.37
|
--
|
12.49
|
13.66
|
--
|
Net Margin
-8.39
Lower than Peers by 14.53
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-8.39
|
4.37
|
--
|
--
|
--
|
|
Peer Median
|
6.14
|
5.63
|
2.96
|
2.70
|
--
|
Cash Profit Margin
0.92
Higher than Peers by 0.92
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
0.92
|
10.12
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
0.00
|
0.00
|
--
|
Revenue Growth
27.08
Lower than Peers by 25.77
Year on year growth in net sales
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
27.08
|
--
|
--
|
--
|
--
|
|
Peer Median
|
52.85
|
--
|
39.85
|
38.90
|
--
|
EBIT Growth
-298.80
Lower than Peers by 512.36
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-298.80
|
--
|
--
|
--
|
--
|
|
Peer Median
|
213.56
|
--
|
20.42
|
176.64
|
--
|
Net Profit Growth
-348.14
Lower than Peers by 558.19
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-348.14
|
--
|
--
|
--
|
--
|
|
Peer Median
|
210.06
|
--
|
12.85
|
218.06
|
--
|
EPS Growth
-348.14
Lower than Peers by 550.92
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-348.14
|
--
|
--
|
--
|
--
|
|
Peer Median
|
202.77
|
--
|
33.33
|
200.00
|
--
|
Book Value Growth
-7.95
--
Year on year growth in book value per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-7.95
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.85
Higher than Peers by 0.61
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
0.85
|
0.34
|
--
|
--
|
--
|
|
Peer Median
|
0.24
|
0.22
|
0.20
|
0.19
|
--
|
Short term debt to equity ratio
0.09
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
0.09
|
0.06
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.46
Lower than Peers by 0.59
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
1.46
|
2.30
|
--
|
--
|
--
|
|
Peer Median
|
2.06
|
1.99
|
2.03
|
1.95
|
--
|
Quick Ratio
0.75
Lower than Peers by 4.67
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
0.75
|
1.03
|
--
|
--
|
--
|
|
Peer Median
|
5.42
|
--
|
1.12
|
1.24
|
--
|
Interest Coverage
-1.77
Lower than Peers by 5.72
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
-1.77
|
3.89
|
--
|
--
|
--
|
|
Peer Median
|
3.95
|
4.14
|
2.98
|
3.48
|
--
|
Operating Efficiency
Debtors to sales
18.71
Lower than Peers by 31.49
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
18.71
|
17.88
|
--
|
--
|
--
|
|
Peer Median
|
50.20
|
--
|
29.85
|
41.06
|
--
|
Asset Turnover
0.59
Lower than Peers by 2.34
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
0.59
|
0.52
|
--
|
--
|
--
|
|
Peer Median
|
2.93
|
--
|
1.55
|
3.06
|
--
|
Receivable days
59.81
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
59.81
|
65.25
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
106.86
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
106.86
|
130.26
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
57.11
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
57.11
|
114.67
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
109.56
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
109.56
|
80.84
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
--
|
31.28
|
--
|
--
|
--
|
|
Peer Median
|
34.50
|
44.20
|
39.23
|
34.42
|
--
|
Price / Book Value
1.78
Lower than Peers by 0.17
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
1.78
|
2.12
|
--
|
--
|
--
|
|
Peer Median
|
1.95
|
2.96
|
2.56
|
2.03
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
57.24
Higher than Peers by 42.77
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
57.24
|
23.35
|
--
|
--
|
--
|
|
Peer Median
|
14.46
|
23.15
|
24.73
|
22.79
|
--
|
Market Cap
14
Lower than Peers by 32
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Hamps Bio
|
14
|
19
|
--
|
--
|
--
|
|
Peer Median
|
47
|
55
|
58
|
40
|
--
|